A vs B [Design Issues]

posted by mittyri – Russia, 2020-02-03 21:05 (632 d 16:17 ago) – Posting: # 21136
Views: 2,299

Hi John,

citing our Hero:

If one is really interested in λz and has no SD-phase in the study, sampling should continue until concentrations from previous doses are washed out – I would expect any estimate within the MD-profile to be biased towards faster elimination.

» I have seen both designs but I (and my former bosses) prefer method A. The only drawback I see from A is it takes longer time.

why does A take longer time?


Edit: Changed to internal link; see also this post #7[Helmut]

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,760 posts in 4,550 threads, 1,547 registered users;
online 32 (0 registered, 32 guests [including 6 identified bots]).
Forum time: Thursday 14:23 CEST (Europe/Vienna)

Always remember that you are absolutely unique.
Just like everyone else.    Margaret Mead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5